Soleus Capital Management, L.P.

Position in TNGX — Tango Therapeutics, Inc.

CIK 1802630 GREENWICH, CT

Position in TNGX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$22,163,340

+$12,749,340 QoQ

Shares Held

709,000

+57.6% QoQ

Ownership

0.420%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

#47

of 247 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. TNGX ranks #20 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	939,254	$349,092,534
2	CELC	Celcuity Inc.	1,704,318	$178,305,749
3	TGTX	Tg Therapeutics, Inc.	2,927,895	$160,858,551
4	RIGL	Rigel Pharmaceuticals Inc	1,843,504	$72,117,876
5	VCEL	Vericel Corp	1,459,152	$64,917,672
6	PRAX	Praxis Precision Medicines, Inc.	177,517	$59,430,916
7	GERN	Geron Corp	42,808,659	$54,795,083
8	ERAS	Erasca, Inc.	2,700,000	$49,464,000

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,163,340	709,000	+57.6%	Shares	Sole	2026-08-11
2026-03-31	$9,414,000	450,000	+4400.0%	Shares	Sole	2026-05-14
2025-12-31	$88,600	10,000	-96.7%	Shares	Sole	2026-02-12
2025-09-30	$2,520,000	300,000	-58.9%	Shares	Sole	2025-11-14
2025-06-30	$3,737,600	730,000	+112.7%	Shares	Sole	2025-08-15
2024-09-30	$2,642,270	343,152	-67.3%	Shares	Sole	2024-11-14
2024-06-30	$9,008,099	1,049,895	-22.2%	Shares	Sole	2024-08-14
2024-03-31	$10,720,151	1,350,145	+59.4%	Shares	Sole	2024-05-15
2023-12-31	$8,386,735	847,145	-56.1%	Shares	Sole	2024-02-14
2023-09-30	$21,720,753	1,929,019	+8.6%	Shares	Sole	2023-11-14
2023-06-30	$5,899,298	1,776,897	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.